Neurogastrx

Neurogastrx, Inc. is a privately held, late clinical-stage biopharmaceutical company based in MA, MA, United States. The company is focused on developing therapies for patients suffering from serious gastrointestinal (GI) diseases, with a pipeline consisting of treatments for GLP-1 induced nausea and vomiting, as well as gastroparesis.